Health
DLnano-vaccines may be a promising strategy for cancer immunotherapy – News-Medical.Net
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in the…
Reviewed by Emily Henderson, B.Sc.Sep 10 2020
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in therapeutic and prophylactic settings.
One of the advantages of synthetic DNA technologies over other methods is the versatility of the platforms. DLnano-vaccines may be designed for various cance…
-
General15 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
General14 hours agoCarrie Bickmore pays tribute to Isaac Smith and Scott Selwood after gruelling marathon
-
Noosa News14 hours agoSuspicious fire, Glenview – Sunshine Coast
-
General22 hours agoRussian strikes kill at least ten in ‘horrific attack’ on Ukraine’s capital of Kyiv